Colin Charles Tièche

University of Bern — Switzerland

Medicine · Health Sciences

5h-index190citations14works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(4), Lung Cancer Treatments and Mutations(4), Cancer therapeutics and mechanisms(4), Lung Cancer Research Studies(4), Forensic and Genetic Research(3)

Publications14 total

Who threw that stone? A study on DNA transfer
Forensic Science International Genetics·2024· 3 citedOpen Access
Human background DNA on stones in an urban environment
Forensic Science International Genetics·2023· 4 citedOpen Access
DNA on the inside door handles of entrance doors
Forensic science international. Genetics supplement series·2022· 3 cited
Efficient DNA Sampling in Burglary Investigations
Genes·2021· 9 citedOpen Access
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
Neoplasia·2018· 62 citedOpen Access
Culling Less Fit Neurons Protects against Amyloid-β-Induced Brain Damage and Cognitive and Motor Decline
Cell Reports·2018· 50 citedOpen Access
Culling less fit neurons protects against amyloid-β-induced brain damage and cognitive and motor decline
2018Open Access
Characterizing the DNA damage response in putative stem cells of resected normal lung and matched NSCLC patient samples
Annals of Oncology·2017
Schedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells
Cancer Cell International·2016· 12 citedOpen Access
22P Increased schedule-dependent efficiency of pemetrexed–cisplatin combination therapy eliminates resistant lung cancer stem-like cells associated with EMT
Journal of Thoracic Oncology·2016
23P Prolonged pemetrexed pretreatment increases efficiency of ionizing radiation combination therapy and correlates with the persistence of treatment-induced DNA damage in lung cancer cells
Journal of Thoracic Oncology·2016Open Access
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
BMC Cancer·2016· 46 citedOpen Access
Additional file 4: Figure S4. of Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
Figshare·2016· 1 citedOpen Access
Additional file 2: Figure S2. of Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
Figshare·2016Open Access

Frequent Co-authors

Laurène Froment(8), Ren‐Wang Peng(8), Patrick Dorn(8), Thomas M. Marti(8), Ralph A. Schmid(6), Martin Zieger(4), Sabina Berezowska(2), Dina S. Coelho(2), Silvia Schwartz(2), Marisa M. Merino(2), Barbara Hauert(2), Barbara Topfel(2), Christa Rhiner(2), Eduardo Moreno(2), Markus Dubach(2), Aileen Sorg(2), Ralph Schmid(2), Yanyun Gao(1), Elias D. Bührer(1), Nina Hobi(1)